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250a Monday, February 22, 2010cpSRP is unique among SRPs in being devoid of RNA. cpSRP consists of an
evolutionarily conserved 54-kDa subunit (cpSRP54) and an unique 43-kDa
subunit (cpSRP43). cpSRP43 subunit has four-ankyrin repeat domain at the
N terminus and a C-terminal chromo domain (CD). The C-terminal CD of
cpSRP43 has been shown to provide interaction sites for the cpSRP54 subunit.
In addition, the chromodomain in the cpSRP43 subunit is also believed to be
important for the formation of the transit complex with LHCP. In this context,
we embarked on the structural characterization of the C-terminal CD using a va-
riety of biophysical techniques including multidimensional NMR spectroscopy.
Far UV circular dichroism spectrum of CD shows that the backbone of the pro-
tein is predominantly in the helical conformation. 1H-15N HSQC spectrum of
CD is well- dispersed suggesting that the protein is structured. Complete reso-
nance assignments (1H, 15N and 13C) in CD have been accomplished using
a variety of triple resonance experiments. Chemical shift index plots show
that CD is an a þ b protein. A detailed analysis of the three-dimensional solu-
tion structure of CD will be presented. The three-dimensional solution structure
of CD provides valuable insights into the molecular mechanism underlying the
post-translational transport and integration of LHCP on the thylakoid mem-
brane.
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Lester Carter1, Maggie Gabanyi2, Helen M. Berman2, Paul Adams1.
1LBL, Berkeley, CA, USA, 2Rutgers, New Brunswick, NJ, USA.
The Protein Structure Initiative (PSI) Structural Genomics KnowledgeBase
(SGKB) technology portal is an online database of PSI-derived technologies.
Information within the portal will be of use to scientists involved in all branches
of molecular biology. Advances are described in all stages of the protein pro-
duction pipeline, from initial target selection to cloning, expression, structure
solution and structure analysis. Information is provided on robotics, high-
throughput protocols, and software development.
The url for the website is: http//:technology.lbl.gov/portal/
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The Protein Structure Initiative Material Repository (PSI-MR; http://psimr.a-
su.edu) provides centralized storage and distribution for the growing collection
of more than 80,000 protein expression plasmids created by PSI researchers.
These plasmids are an invaluable resource that allows the research community
to dissect the biological function of proteins whose structures have been iden-
tified by the PSI. The plasmid annotation, which includes the full length se-
quence, vector information, and associated publications, is stored in a freely
available, searchable database called DNASU (http://dnasu.asu.edu). Each
PSI plasmid is also linked to a variety of additional resources, including the
PSI Structural Genomics Knowledgebase (PSI-SGKB: http://kb.psi-structural-
genomics.org), which facilitates cross-referencing of a particular plasmid to
protein annotations and experimental data. Nearly 16,000 PSI plasmid samples
are currently available and can be requested directly though the website. The
PSI-MR has also developed a novel strategy to avoid the most common concern
encountered when distributing plasmids, namely the complexity of material
transfer agreement (MTA) processing and the resulting delays this causes. It
is in this context that we developed and successfully implemented the Expe-
dited Process MTA, in which we created a network of institutions that agree
to the terms of transfer in advance of a material request, thus eliminating the
delay researchers would typically encounter while their institution is processing
the MTA. Our hope is that by creating a repository of expression-ready plas-
mids and expediting the process for receiving these plasmids, we will help ac-
celerate the accessibility and pace of scientific discovery.
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New York, NY, USA, 6Arizona State University, Tempe, AZ, USA.The Protein Structure Initiative Structural Genomics Knowledgebase (PSI
SGKB, URL: http://kb.psi-structuralgenomics.org) is a web resource designed
to turn the products of the structural genomics and structural biology efforts
into knowledge that can be used by the biological community to understand liv-
ing systems and disease. We will present examples and demonstrate how to use
the PSI SGKB to enable biological research. For example, a protein sequence
or PDB ID search will provide a list of protein structures from the Protein Data
Bank, associated biological descriptions (annotations), homology models,
structural genomics protein target information, experimental protocols, and
the ability to order available DNA clones. A text search will find technology
reports and publications that were created by the PSI’s high-throughput re-
search efforts. Web tools that aid in bench top research, such as protein con-
struct design, are also available. Created in collaboration with the Nature Pub-
lishing Group, the Structural Genomics Knowledgebase Gateway provides
a research library, editorials about new research advances, news, and an events
calendar also present a broader view of structural genomics and structural bi-
ology. The PSI SGKB is funded by the NIGMS.
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The primary goal of the Protein Structure Initiative:Biology (PSI:Biology) to
be funded by the National Institute of General Medical Sciences (NIGMS) is
to apply high-throughput structural biology to important biological problems
(http://www.nigms.nih.gov/Initiatives/PSI/psi biology/). This will be accom-
plished by establishing partnerships between centers for structure determina-
tion and biologists with interests in particular proteins or collections of pro-
teins. The PSI:Biology network centers will include: 1) Centers for High-
Throughput Structure Determination, 2) Centers for Membrane Protein Struc-
ture Determination, 3) the PSI:Materials Repository, and 4) the PSI:Biology
Knowledgebase. The partnerships, established through Consortia for High-
Throughput-Enabled Structural Biology Partnerships, will define targets for
structure determination and provide funds for functional studies in the appli-
cants’ laboratories and for a portion of the cost for structure determination in
the center. In addition to protein structures and models, the PSI:Biology net-
work will generate and make available reagents and plasmids for expressed
proteins to support functional studies in the research community. NIGMS en-
courages Partnership applications from biologists or groups of biologists
with biological questions that will benefit from the determination of relevant
protein structures. The PSI:Biology high-throughput approach will enable ex-
amination of families of proteins related to the target proteins, an approach
that has proven highly successful in generating the first structure of a family
member and then allowing many other family members to be modeled. Exam-
ples of current partnerships include using structural genomics, modeling and
systems biology to generate a three-dimensional reconstruction of the central
metabolic network of the bacterium, Thermotoga maritima, and the discovery
of novel enzymatic mechanisms for the enoylase and amido hydrolase classes
of enzymes. Additional opportunities for researchers to join the PSI:Biology
network will be provided through ongoing and future program announcements.
Researchers may also suggest proteins for structure determination through the
PSI Community Nomination site at: http://cnt.psi-structuralgenomics.org/
CNT/targetlogin.jsp.
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The Center for Eukaryotic Structural Genomics (CESG) aims to be the leading
center for developing and disseminating tested technologies to efficiently solve
structures of eukaryotic proteins. We create, evaluate, and optimize innovative
protocols for producing eukaryotic proteins in active forms. We seek to im-
prove the efficiency of all stages from target selection-design to three-dimen-
sional structure determination by X-ray crystallography or NMR spectroscopy,
including development of bioinformatic techniques and LIMS tools. Using our
protein production platform, we refine methods for improving the yield of
structures from high-value targets, in particular proteins from humans and other
vertebrates. CESG has a substantial outreach component; more than 400 targets
from outside requestors have been accepted for study with a structure success
rate of 5%, which compares favorably with the eukaryotic success rates for the
Monday, February 22, 2010 251atotal PSI effort. These eukaryotic targets frequently present unique challenges.
All CESG protein production protocols and Technology Dissemination Reports
are accessible through the PSI Knowledgebase: http://kb-psi-structuralgeno-
mics.org/KB/ and CESG’s website. Selected technology developments are pre-
sented here. These include advances in expression vector design, enhanced
methodology for cell based and wheat germ cell-free expression systems,
new software to improve the quality and reduce time for structure determina-
tion by X-ray crystallography and NMR, and optimized techniques for the pro-
duction of TEV protease for use in our protein production platform. We ac-
tively share our advances with the biotechnology, pharmaceutical, and
academic communities through collaborations, oral presentations, peer-re-
viewed articles, submissions to public databases and material distribution chan-
nels, including PepcDB, PDB, BMRB, PSI Materials Repository, and technol-
ogy transfer workshops.
Supported by NIH/NIGMS Protein Structure Initiative grants GM074901 and
GM064598. We acknowledge ALL members of the CESG team for their ded-
icated work.
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Protein crystallization is still a major bottleneck in structural biology. As the
current methodology of protein crystallization is a type of screening, it is usu-
ally difficult to crystallize important target proteins. The hetero-epitaxial
growth from the surface of mineral crystal as a nucleant had been thought
to be effective to enhance the chance of protein crystallization. However, gen-
erally applicable hetero-epitaxial nucleants for protein crystallization have
never been found. Recently, we have reported a protein crystallization method
using synthetic zeolite molecular sieves as a hetero-epitaxic nucleant. This
method is based on the packing space expansion of protein crystals by a di-
rected nucleation on the material surface, thereby providing new crystal forms
with a substantial improvement of diffraction quality in some cases. In this
work, a sparse matrix crystallization screening experiment of xylanase from
Trichoderma longibrachiatum was performed with and without molecular
sieves, using a commercially available sparse matrix screening kit. A result
of crystallization screening of xylanase showed that molecular sieves promotes
the crystallization of xylanase, suggesting that the hetero-epitaxic nucleate ap-
proach allows us to improve the effectiveness of the sparse matrix screening of
protein crystallization. Interestingly, molecular sieves 5A and 13X provided
a new crystal form under the crystallization condition containing zinc, in
which a zinc-mediated protein sheet looked favorable for the hetero-epitaxic
3D crystal growth.
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We have undertaken a small-scale structural genome project focusing on
S. cerevisiae ORFs without characterized functional motifs or known primary
sequence homologs. The cloning, expression and purification screening of 9 tar-
gets sequences, led to the determination of the crystal structure of Yer067w by
Multiple Anomalous Diffraction at 1.7 A˚ resolution. This 20 KDa protein pres-
ent an alpha-beta fold where the 7-stranded beta-sheet is backed by 4 alpha-he-
lices on one side. Interestingly, a structure-based search using the servers SSM
or DALI retrieved only proteins with insignificant superposition scores, indicat-
ing that Yer067w represents a novel fold superfamily. The phylogenetic anal-
ysis of Yer067w primary sequence homologs showed that this protein belongs
to a well-conserved family exclusive to Ascomycetes. To further understand
Yer067w role we have searched for functional hints using yeast strains deleted
for this gene and its paralog YIL057C. Microarray analysis of Dyer067w re-
vealed important modifications in expression of genes related to oxidative
phosphorylation, amino acids and lipid metabolism. In a screening for pheno-
types, we verified that all mutants presented growth deficiencies in non fermen-
tative carbon sources and Western bolt analysis showed that the presence of
both proteins are tightly linked to growth on respiratory substrates or low nu-
trient conditions, suggesting that both proteins are important to the metabolismin glucose free media. Furthermore, Yer067w mutants revealed an antifungal
drug resistance phenotype, presenting an increment of 2 times in the MIC for
Nystatin and anphotericin B. This work highlights the importance of functional
characterization of unknown ORFs for the comprehension of yeast cells metab-
olism and for uncover new regulatory elements. Support: FAPERJ, CNPq,
CIHRProtein Aggregates I
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Oligoalanines with greater than ca. 14 residues, which have been doped with
charged residues (e.g. lysine), usually adopt a-helical conformations in aque-
ous media.1 In contrast, Ac-(AAKA)4-NH2 aggregates instantaneously when
dissolved in aqueous media at concentrations ranging from 70 mM to 7 mM.
Evidence from UV circular dichroism (UV-CD) and FTIR spectroscopies sug-
gest a mostly b-sheet like conformation. Kinetics studies of the initially formed
conformations suggest a transition from a mostly b-like to a mostly PPII-like
conformation, in contrast to typical fibril formation/growth studies. AFM im-
ages of freshly prepared samples indicate a porous, tissue-like architecture. Ad-
dition of salts (e.g. NaCl) stabilizes this architecture, resulting in the formation
of a macroscopic hydrogel. b-sheet and hydrogel formation by such an amino
acid sequence is quite unusual, as it does not obey typical rules required for
peptide hydrogel formation. In particular, there are no alternating complimen-
tary charges, nor alternating hydrophilic and hydrophobic residues. Without the
added stabilization provided by the addition of salts, however, the peptide tran-
sitions from a mostly b-sheet-like structure to a PPII-like conformation, possi-
bly via triple helix formation, as evidenced by both electronic and vibrational
CD. AFM images suggest the formation of a heterogeneous mixture of assem-
blies, including bead-like filaments as well as networks of well-defined, inter-
twined fibrils. Potential applications for peptide hydrogels include drug deliv-
ery devices and tissue engineering scaffolds. In this regard, release studies of
model peptides which have been trapped within the peptide hydrogel will be
presented, as well as rheological characterization of the hydrogel as a function
of salt and peptide concentration.
[1] Scholtz, J. M.; Marqusee, S.; Baldwin, R. L.; York, E. J.; Stewart, J. M.;
Santoro, M.; Bolen. D. W. Natl. Acad. Sci. U.S.A. 1991, 88, 2854-2860.
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The 8-residue alanine oligopeptide, Ac-A4KA2Y-NH2(AKY8), was found to
form amyloid-like fibrils upon incubation at room temperature in acidified
aqueous solution, at peptide concentrations > 10 mM. The fibril solution ex-
hibits an enhanced VCD couplet in the amide I’ band region, which is nearly
2 orders of magnitude larger than typical polypeptide/protein signals in this re-
gion. Such intensity enhancements have recently been observed for insulin and
lysozyme fibrils.1 We performed simulations of the VCD and IR amide I’ band
profile using a simplified excitonic coupling model. Preliminary results suggest
that inter-sheet coupling is responsible for the VCD intensity enhancement. The
UV-CD spectrum of the fibril solution shows circular dichroism in the region
associated with the tyrosine side chain absorption. A similar peptide, Ac-
A4KA2-NH2 (AK7), lacking in a terminal tyrosine residue, does not aggregate.
These results suggest a pivotal role for the C-terminal tyrosine residue in sta-
bilizing the aggregation state of this peptide. It is speculated that interactions
between the lysine and tyrosine side chains of consecutive strands in an anti-
parallel arrangement, e.g. via cation-p interactions, are responsible for the sta-
bilization of the resulting fibrils. These results offer considerations and insight
for the de novo design of self-assembling oligopeptides for biomedical and bio-
technological applications, and highlight the usefulness of VCD as a tool to
probe amyloid fibril formation.
[1] Ma, S.; Cao, X.; Mak, M.; Sadik, A.; Walkner, C.; Freedman, T.B.; Lednev,
I.K.; Dukor, R.K.; Nafie, L.A. J. Am. Chem. Soc.2007, 129, 12364-12365.
